Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yeah saw they put back in that cheaky 0.03% again, and according to trends when they put it in a few days later the sp pops and news comes out.... then they take the 0.03% out after and the sp drifts down.... soooo what could be coming within the next few days? ?
Yeah saw they put back in that cheaky 0.03% again, and according to trends when they put it in a few days later the sp pops and news comes out.... then they take the 0.03% out after and the sp drifts down.... soooo what could be coming within the next few days? ?
Lombard sitting here with a plus £23m investment, three weeks to AGM, three months to FDA results. Surely positive information coming from the AGM, must be time for the share price to finally , slowly start advancing on forth coming news. Fingers crossed guys and girls!
Sadly appears so. Naughty FUM.
Looks like your exhortations fell on deaf ears, Darth!
Cmon futura, it's jubilee week, for queen and country... LFG!!!!
AGM should be due in months time, all starting to heat up shortly I would suggest, really looking forward to the launch of Eroxon. See what the strategy is along with their worldwide partners, should be exciting times for all that have been here years, have to say I believe both the company and long term share holders deserve success and reward for the longevity and verbal attacks that have been made over the years.
Great appointments to strengthen the board have been put in place in recent times. Launching in September along with hopeful approval from the FDA sounds like a great recipe to me, those combined alone should bring great publicity. If I’m correct it would in my eyes be a great strategy for launch.
Not long now, let’s hope we are all raising a glass in the not to distant future, Futura and Eroxon!
This statement from 26 April RNS confirms product will be launched sooner rather than in 2023! The Company is now preparing for first product launches over the next year and 2023, not just in Europe but also countries! 2023 being US so where they have approval they will be launching product 2022 no mention of delayed launch!
launch after fda make sense
All the below comments below are a reflection of the communication and holding off of the BOD to launch, hence why we all are speculating . Had FUM been clear in their comms on launch timelines then we would not need to speculate and come up with our own theories. Fuzzy wuzzy comms by barder and co does not give certainty to the market
Are we launching in the UK before the FDA submission ?
Are we waiting for FDA submission first?
My understanding was launch in the EU will be in the next 10 months?
true, but at the same time they have never had such a strong product as this. im not worried about the price now, I'll just wait for the real game changing news later. any other news and I think you are right, it will go higher and then gradually retreat.
£ 100 befor year
I very much like the tie up with Coopers, American results due in just over three months time. FUM have full control of Med 3000, but having gone down the path of using various partners they now have to deliver in both supply of the product and support. We all know how things have and are changing in recent times with delivery, fulfilling these tasks will be no mean feat in days like today,we know FUM is a small company, they will likely and hopefully be inundated with demands from across the world. It just does not happen that easily and will be new to FUM. Probably new staff etc etc. It all just doesn’t happen. Last thing we as long term shareholders need now is for it all to go wrong due to rushing, I am sure they must be extremely busy in getting everything ready and at the same time liaising with the various partners.
I would suggest that all that needs to be sorted prior to launch is a massive undertaking, so although frustrated we need a little more patience, they simply cannot afford to **** this up.
re your question, maybe they're holding off til FDA approval because they expect to be bought out soon after it happens, so no point getting things going that a parent company will want to change once they takeover?
Just a theory. Surely this will be a takeover target upon approval. Safer and easier to use than viagra plus it's OTC too. Truly sitting on a pharma goldmine here.
GLA.
Indeed. Its mind boggling wondering why they have held off launching in eu/uk since they first got approval! Would have been well marketed and establoshed by now with decent amount of sales data to boot.
I believe or hope this will be on sale by Q3, makes no sense to hold off as can only strengthen their bargaining position with the US if sales are good! Granted they need some good marketing in uk/EU but for the life of me I can’t see why they would hold off until the US deal is done! Just makes no sense!
I agree with sentiments below. I've also held this share for around 15 yrs, everytime there is some good news it climbs but retreats back and often below it's previous low. It's very frustrating. Would be wonderful to see some sustained climbing rather than the stagnation around 30p
Trinity Delta-
Interestingly, as part of its due diligence, Cooper undertook a consumer marketing home use test (HUT) in the UK, France, and the Netherlands. The size of the HUT is not disclosed but would typically involve c 200 consumers. In this case men with self-diagnosed ED were supplied a four-pack sample of MED3000 with the appropriate packaging leaflet. The results were in line with those seen in the FM57 1,000 patient clinical trial, where over two-thirds of patients saw a clinically meaningful benefit. The importance of the HUT lies in the confirmation that MED3000 works as expected in a real-world setting.
One does not have to be in marketing to appreciate the importance of a timely launch. The BoD have had a few false starts, so I am guessing they are committed to getting it right this time. We have to accept that the BoD are in control and driving it according to their learning curve. Perhaps a coordinated launch (?)
I trust the product more than the BoD. It is what it is!
"Even limited success in these larger markets could transform Futura Medical, in our view."
- Trinity Delta
I share your frustration dosanddonts and also your positivity as well as milktray and other board members.
But it’s time we had realistic forecasts and timescales from Barder. This is a share owning company, not a Barder fiefdom. He can afford to take his time as he’s well paid for doing very little in my opinion - and I’ve been an investor here for more than 15 years.
His talk of ‘we’re working hard’ rings hollow - the CE marking was approved a year ago - the diclofenic application using dermasys seems to be somewhere in the long grass and even less is heard about carbonide use.
I want some measure of ongoing accountability from the BoD - I don’t want to hear wishywashy information. If we can’t know financial impact numbers, then I want to know product availability dates both here in the UK and the others areas Latin America, Asia etc
Their absence is the prime reason the sp is in the doldrums - the board has to reflect that the sp is nowhere near the 40p placing let alone the higher numbers prior to the board taking advantage of that fact so they could do the placing at a discount.
Barder is arrogant in his dismissal of justified shareholder questions. Finally, look at the website - nothing’s changed since it was put up - pathetic !
Thanks for that , so having given it some thought , the sales launches will happen post FDA submission and thumbs up from FDA as that will de risk the product for longer term usage by users (which was one of the test criteria for FM71) and then allow for a full product launch with confidence into the various regions
Found this Trinity Delta:
The launch timings have not been detailed; however the nature of the pharmacy market varies across Europe with countries such as the UK and Netherlands dominated by large retail chains. We suspect these will be the initial launch markets (probably in 2023), with retailers actively contributing to the promotional messaging. The next wave would likely include the key markets of France, Belgium, Germany, Italy, and Spain, with the third wave being the distributor-led smaller geographies. Even limited success in these larger markets could transform Futura Medical, in our view.
I’m a little peed that no more information has been released today as this was not a quick decision on FUM’s part who have been in talks for years! They are a shareholder owned company so tell us what is going on if I hear 12month or 6month once more for gods sake! Cooper from what I can see haven’t even released any news relating to the collaboration?? Maybe not a big deal for them?
Silly question on my part, why should the company await for the FDA submission and then approval for the release of figures ? All of this years news seems to be derisking the share price as news flows in on new license agreements to a HOLD state. Its the release of when they will actually start selling and in what form and some sales figures that will move this stock to a BUY state and send it northwards which i am am sure we will get.
Ia m really hoping on news that says " we will be launching the product in the EU/Uk region on so on date alongside a marketing campaign to compliment the drive by our distributor Coopers across x number of countries"
Realistically i think we will get " Coopers will be driving a flagship launch at XX country with a soft marketing campaign"
Again all speculation on my part , but at least we are lining up the ducks one by one and in a better position than before and have to just be patient as this will take some time i feel
Obviously, with little information for the market/analysts to hang their hats on, the SP will remain unpredictable. However, there has now been positive movement, this should underpin the SP to current levels. All the bricks are now in position, barring the big one. Once it's approved by FDA, US deal should follow along with the much-awaited release of numbers. Until then, the SP will behave like some covid stocks which trade on residual potential.